AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 88 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $44,116 | +55.3% | 97,927 | 0.0% | 0.00% | – |
| Q1 2023 | $28,399 | -27.0% | 97,927 | +13.3% | 0.00% | – |
| Q4 2022 | $38,883 | +8.0% | 86,425 | +24.9% | 0.00% | – |
| Q3 2022 | $36,000 | +2.9% | 69,209 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -95.4% | 69,209 | -79.3% | 0.00% | – |
| Q1 2022 | $768,000 | -53.8% | 333,741 | -4.6% | 0.00% | – |
| Q4 2021 | $1,661,000 | -42.9% | 349,688 | -4.4% | 0.00% | -100.0% |
| Q3 2021 | $2,907,000 | +13.4% | 365,703 | -0.7% | 0.00% | – |
| Q2 2021 | $2,564,000 | -28.3% | 368,340 | -18.4% | 0.00% | -100.0% |
| Q1 2021 | $3,574,000 | -5.5% | 451,320 | -6.1% | 0.00% | 0.0% |
| Q4 2020 | $3,782,000 | +13.1% | 480,584 | +1.9% | 0.00% | 0.0% |
| Q3 2020 | $3,345,000 | -27.5% | 471,641 | -5.5% | 0.00% | 0.0% |
| Q2 2020 | $4,615,000 | +234.4% | 498,924 | +68.4% | 0.00% | – |
| Q1 2020 | $1,380,000 | -38.5% | 296,279 | +0.9% | 0.00% | -100.0% |
| Q4 2019 | $2,244,000 | -3.4% | 293,724 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $2,324,000 | +44.6% | 302,214 | +28.8% | 0.00% | – |
| Q2 2019 | $1,607,000 | -7.5% | 234,621 | +8.6% | 0.00% | – |
| Q1 2019 | $1,738,000 | +27.0% | 215,956 | +18.2% | 0.00% | – |
| Q4 2018 | $1,369,000 | -21.3% | 182,749 | +0.5% | 0.00% | – |
| Q3 2018 | $1,740,000 | -7.2% | 181,835 | +2.6% | 0.00% | – |
| Q2 2018 | $1,874,000 | +935.4% | 177,184 | +870.0% | 0.00% | – |
| Q1 2018 | $181,000 | +103.4% | 18,266 | +10.7% | 0.00% | – |
| Q4 2017 | $89,000 | +9.9% | 16,495 | 0.0% | 0.00% | – |
| Q3 2017 | $81,000 | +26.6% | 16,495 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | -48.0% | 16,495 | 0.0% | 0.00% | – |
| Q1 2017 | $123,000 | – | 16,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |